ABSTRACT
Arthropod-borne viruses represent a crucial public health threat. Current arboviral serology assays are either labor intensive or incapable of distinguishing closely related viruses, and many zoonotic arboviruses that may transition to humans lack any serologic assays. In this study, we present a programmable phage display platform, ArboScan, that evaluates antibody binding to overlapping peptides that represent the proteomes of 691 human and zoonotic arboviruses. We confirm that ArboScan provides detailed antibody binding information from animal sera, human sera, and an arthropod blood meal. ArboScan identifies distinguishing features of antibody responses based on exposure history in a Colombian cohort of Zika patients. Finally, ArboScan details epitope level information that rapidly identifies candidate epitopes with potential protective significance. ArboScan thus represents a resource for characterizing human and animal arbovirus antibody responses at cohort scale.
Subject(s)
Antibodies, Viral , Arboviruses , Humans , Arboviruses/immunology , Arboviruses/isolation & purification , Animals , Antibodies, Viral/immunology , Antibodies, Viral/blood , Peptides/immunology , Peptides/chemistry , Zika Virus Infection/virology , Zika Virus Infection/immunology , Zika Virus Infection/blood , Zika Virus/immunology , Epitopes/immunology , Serologic Tests/methods , Arbovirus Infections/virology , Arbovirus Infections/immunology , Proteome , Colombia , Female , Peptide Library , Cell Surface Display Techniques , MaleABSTRACT
Aedes aegypti, the mosquito that transmits arboviral diseases such as dengue (DENV), chikungunya (CHIKV), and Zika viruses (ZIKV), is present in tropical and subtropical regions of the world. Individuals at risk of mosquito-borne disease (MBD) in the urban tropics face daily challenges linked to their socio-environment conditions, such as poor infrastructure, poverty, crowding, and limited access to adequate healthcare. These daily demands induce chronic stress events and dysregulated immune responses. We sought to investigate the role of socio-ecologic risk factors in distress symptoms and their impact on biological responses to MBD in Machala, Ecuador. Between 2017 and 2019, individuals (≥ 18 years) with suspected arbovirus illness (DENV, ZIKV, and CHIKV) from sentinel clinics were enrolled (index cases, N = 28). Cluster investigations of the index case households and people from four houses within a 200-m radius of index home (associate cases, N = 144) were conducted (total N = 172). Hair samples were collected to measure hair cortisol concentration (HCC) as a stress biomarker. Blood samples were collected to measure serum cytokines concentrations of IL-10, IL-8, TNF-α, and TGF-ß. Univariate analyses were used to determine the association of socio-health metrics related to perceived stress scores (PSS), HCC, and immune responses. We found that housing conditions influence PSS and HCC levels in individuals at risk of MBD. Inflammatory cytokine distribution was associated with the restorative phase of immune responses in individuals with low-moderate HCC. These data suggest that cortisol may dampen pro-inflammatory responses and influence activation of the restorative phase of immune responses to arboviral infections.
Subject(s)
Arbovirus Infections/epidemiology , Arbovirus Infections/psychology , Immune System Diseases/complications , Stress, Psychological/complications , Adult , Animals , Arbovirus Infections/immunology , Biomarkers/analysis , Biomarkers/blood , Cohort Studies , Cytokines/blood , Ecosystem , Ecuador/epidemiology , Family Characteristics , Female , Hair/chemistry , Health Services Accessibility , Housing/classification , Housing/standards , Humans , Hydrocortisone/analysis , Hydrocortisone/metabolism , Immune System Diseases/epidemiology , Logistic Models , Male , Retrospective Studies , Sociodemographic Factors , Stress, Psychological/immunologyABSTRACT
BACKGROUND: The emergence and re-emergence of infectious diseases are a cause for worldwide concern. The introduction of Zika and Chikungunya diseases in the Americas has exposed unforeseen medical and logistical challenges for public health systems. Moreover, the lack of preventive measures and vaccination against known and emerging mosquito-transmitted pathogens, and the occurrence of unanticipated clinical complications, has had an enormous social and economic impact on the affected populations. In this study, we aimed to measure the seroprevalence of endemic and emerging viral pathogens in military personnel stationed in Manaus, Amazonas state. METHODS: We measured the seropositivity of antibodies against 19 endemic and emerging viruses in a healthy military personnel group using a hemagglutination inhibition assay (HIA). RESULTS: Overall, DENV positivity was 60.4%, and 30.9% of the individuals reacted against ZIKV. Also, 46.6%, 54.7%, 51.3% and 48.7% individuals reacted against West Nile virus (WNV), Saint Louis encephalitis virus (SLEV), Ilheus virus (ILHV) and Rocio virus (ROCV), respectively. Individuals with high DENV HIA titer reacted more frequently with ZIKV or WNV compared to those with low HIA titers. Observed cross-reactivity between Flaviviruses varied depending on the virus serogroup. Additionally, 0.6% and 0.3% individuals were seropositive for Oropouche virus (OROV) and Catu virus (CATUV) from the family Peribunyaviridae, respectively. All samples were negative for Eastern Equine Encephalitis virus (EEEV), Western Equine Encephalomyelitis virus (WEEV), Mayaro virus (MAYV), Mucambo virus (MUCV) and CHIKV from the family Togaviridae. CONCLUSIONS: A high proportion of individuals in our high-risk population (~ 60%) lacked antibodies against major endemic and emerging viruses, which makes them susceptible for further infections. Military personnel serving in the Amazon region could serve as sentinels to strengthen global infectious disease surveillance, particularly in remote areas.
Subject(s)
Antibodies, Viral/blood , Arbovirus Infections/immunology , Arboviruses/immunology , Adult , Age Factors , Arbovirus Infections/epidemiology , Arboviruses/classification , Brazil , Dengue Virus/immunology , Healthy Volunteers , Humans , Male , Middle Aged , Military Personnel/statistics & numerical data , Prevalence , Seroepidemiologic Studies , West Nile virus/immunology , Young Adult , Zika Virus/immunology , Zika Virus Infection/blood , Zika Virus Infection/immunologyABSTRACT
Despite the health, social and economic impact of arboviruses in French Guiana, very little is known about the extent to which infection burden is shared between individuals. We conducted a large multiplexed serological survey among 2697 individuals from June to October 2017. All serum samples were tested for IgG antibodies against DENV, CHIKV, ZIKV and MAYV using a recombinant antigen-based microsphere immunoassay with a subset further evaluated through anti-ZIKV microneutralization tests. The overall DENV seroprevalence was estimated at 73.1% (70.6-75.4) in the whole territory with estimations by serotype at 68.9% for DENV-1, 38.8% for DENV-2, 42.3% for DENV-3, and 56.1% for DENV-4. The overall seroprevalence of CHIKV, ZIKV and MAYV antibodies was 20.3% (17.7-23.1), 23.3% (20.9-25.9) and 3.3% (2.7-4.1), respectively. We provide a consistent overview of the burden of emerging arboviruses in French Guiana, with useful findings for risk mapping, future prevention and control programs. The majority of the population remains susceptible to CHIKV and ZIKV, which could potentially facilitate the risk of further re-emergences. Our results underscore the need to strengthen MAYV surveillance in order to rapidly detect any substantial changes in MAYV circulation patterns.
Subject(s)
Antibodies, Viral/blood , Arbovirus Infections/epidemiology , Arbovirus Infections/immunology , Arboviruses/genetics , Arboviruses/immunology , Adolescent , Adult , Aged , Arbovirus Infections/classification , Arboviruses/classification , Arboviruses/pathogenicity , Child , Child, Preschool , Cost of Illness , Cross-Sectional Studies , Demography , Female , French Guiana/epidemiology , Humans , Immunoglobulin G/blood , Male , Middle Aged , Prevalence , Seroepidemiologic Studies , Young AdultABSTRACT
Reports on tropical infections among kidney transplant (KT) recipients have increased in recent years, mainly because of the growing number of KT programs located in tropical and subtropical areas, and greater mobility or migration between different areas of the world. Endemic in emerging and developing regions, like most countries in Latin America, tropical infections are an important cause of morbidity and mortality in this population. Tropical infections in KT recipients may exhibit different pathways for acquisition compared with those in nonrecipients, such as transmission through a graft and reactivation of a latent infection triggered by immunosuppression. Clinical presentation may differ compared with that in immunocompetent patients, and there are also particularities in diagnostic aspects, treatment, and prognosis. KT patients must be screened for latent infections and immunized properly. Last, drug-drug interactions between immunosuppressive agents and drugs used to treat tropical infections are an additional challenge in KT patients. In this review, we summarize the management of tropical infections in KT patients.
Subject(s)
Arbovirus Infections/diagnosis , Chagas Disease/diagnosis , Kidney Transplantation , Leishmaniasis/diagnosis , Strongyloidiasis/diagnosis , Tuberculosis/diagnosis , Arbovirus Infections/immunology , Arbovirus Infections/therapy , Chagas Disease/immunology , Chagas Disease/therapy , Chikungunya Fever/diagnosis , Chikungunya Fever/immunology , Chikungunya Fever/therapy , Dengue/diagnosis , Dengue/immunology , Dengue/therapy , Graft Rejection/prevention & control , Humans , Immunocompromised Host , Immunosuppressive Agents/therapeutic use , Latin America , Leishmaniasis/immunology , Leishmaniasis/therapy , Strongyloidiasis/immunology , Strongyloidiasis/therapy , Tuberculosis/immunology , Tuberculosis/therapy , Yellow Fever/diagnosis , Yellow Fever/immunology , Yellow Fever/therapy , Zika Virus Infection/diagnosis , Zika Virus Infection/immunology , Zika Virus Infection/therapyABSTRACT
Arbovirus infections represent a global public health problem, and recent epidemics of yellow fever, dengue, and Zika have shown their critical importance in Brazil and worldwide. Whilst a major effort for vaccination programs has been in the spotlight, a number of aptamer approaches have been proposed in a complementary manner, offering the possibility of differential diagnosis between these arboviruses, which often present similar clinical symptoms, as well as the potential for a treatment option when no other alternative is available. In this review, we aim to provide a background on arbovirus, with a basic description of the main viral classes and the disease they cause, using the Brazilian context to build a comprehensive understanding of their role on a global scale. Subsequently, we offer an exhaustive revision of the diagnostic and therapeutic approaches offered by aptamers against arboviruses. We demonstrate how these promising reagents could help in the clinical diagnosis of this group of viruses, their use in a range of diagnostic formats, from biosensors to serological testing, and we give a short review on the potential approaches for novel aptamer-based antiviral treatment options against different arboviral diseases.
Subject(s)
Aptamers, Nucleotide/genetics , Aptamers, Nucleotide/immunology , Arbovirus Infections/diagnosis , Arboviruses/immunology , Serologic Tests/methods , Aptamers, Nucleotide/isolation & purification , Arbovirus Infections/epidemiology , Arbovirus Infections/immunology , Arbovirus Infections/virology , Brazil/epidemiology , Humans , Public Health , Viral Proteins/immunologyABSTRACT
We review and contrast the evidence for an effect of amplifying host herd immunity on circulation and human exposure to arboviruses. Herd immunity of short-lived West Nile virus avian amplifying hosts appears to play a limited role in levels of enzootic circulation and spillover infections of humans, which are not amplifiers. In contrast, herd immunity of nonhuman primate hosts for enzootic Zika, dengue, and chikungunya viruses is much stronger and appears to regulate to a large extent the periodicity of sylvatic amplification in Africa. Following the recent Zika and chikungunya pandemics, human herd immunity in the Americas quickly rose to â¼50% in many regions, although seroprevalence remains patchy. Modeling from decades of chikungunya circulation in Asia suggests that this level of herd immunity will suppress for many years major chikungunya and Zika epidemics in the Americas, followed by smaller outbreaks as herd immunity cycles with a periodicity of up to several decades.
Subject(s)
Arbovirus Infections/immunology , Arboviruses/immunology , Immunity, Herd , Animals , Arbovirus Infections/virology , Arboviruses/genetics , Arboviruses/physiology , HumansABSTRACT
Tick-borne diseases (TBDs) are a growing public health threat and are increasingly identified as the cause of undifferentiated febrile illness. There is a significant gap in our understanding of ticks and their associated pathogens in Ecuador. An arboviral surveillance study allowed us to explore potential exposure to TBDs in febrile subjects. We tested plasma samples from 222 febrile subjects for spotted fever group rickettsial (SFGR) antibodies from southern coastal Ecuador in 2014-2015 via ELISA. Fifty-five (25%) subjects had evidence of anti-SFRG IgG or IgM antibodies. Although attempts to detect Rickettsia species in plasma by polymerase chain reaction were unsuccessful, these preliminary data suggest the possibility of endemic SFGR transmission in Ecuador. To better understand the burden and entomological risk for TBDs in Ecuador, future studies should expand TBD surveillance in humans, document common human-biting ticks, and measure pathogen carriage rates in questing ticks.
Subject(s)
Antibodies, Bacterial/blood , Arbovirus Infections/immunology , Coinfection/microbiology , Coinfection/virology , Spotted Fever Group Rickettsiosis/immunology , Adolescent , Adult , Arbovirus Infections/epidemiology , Child , Coinfection/epidemiology , Ecuador/epidemiology , Female , Fever , Humans , Immunoglobulin M/blood , Male , Middle Aged , Retrospective Studies , Spotted Fever Group Rickettsiosis/epidemiology , Young AdultABSTRACT
Granzyme A (GzmA) is secreted by cytotoxic lymphocytes and has traditionally been viewed as a mediator of cell death. However, a growing body of data suggests the physiological role of GzmA is promotion of inflammation. Here, we show that GzmA is significantly elevated in the sera of chikungunya virus (CHIKV) patients and that GzmA levels correlated with viral loads and disease scores in these patients. Serum GzmA levels were also elevated in CHIKV mouse models, with NK cells the likely source. Infection of mice deficient in type I interferon responses with CHIKV, Zika virus, or dengue virus resulted in high levels of circulating GzmA. We also show that subcutaneous injection of enzymically active recombinant mouse GzmA was able to mediate inflammation, both locally at the injection site as well as at a distant site. Protease activated receptors (PARs) may represent targets for GzmA, and we show that treatment with PAR antagonist ameliorated GzmA- and CHIKV-mediated inflammation.
Subject(s)
Arbovirus Infections/immunology , Chikungunya Fever/immunology , Granzymes/immunology , Inflammation/immunology , Killer Cells, Natural/immunology , Animals , Granzymes/blood , Humans , Mice , Mice, Inbred C57BLABSTRACT
In the context of recent arbovirus epidemics, questions about the frequency of simultaneous infection of patients with different arbovirus species have been raised. In 2014, a major Chikungunya virus (CHIKV) epidemic impacted the Caribbean and South America. As part of ongoing screening of schoolchildren presenting with acute undifferentiated febrile illness in rural Haiti, we used RT-PCR to identify CHIKV infections in 82 of 100 children with this diagnosis during May-August 2014. Among these, eight were infected with a second arbovirus: six with Zika virus (ZIKV), one with Dengue virus serotype 2, and one with Mayaro virus (MAYV). These dual infections were only detected following culture of the specimen, suggesting low viral loads of the co-infecting species. Phylogenetic analyses indicated that the ZIKV and MAYV strains differ from those detected later in 2014 and 2015, respectively. Moreover, CHIKV and ZIKV strains from co-infected patients clustered monophyletically in their respective phylogeny, and clock calibration traced back the common ancestor of each clade to an overlapping timeframe of introduction of these arboviruses onto the island.
Subject(s)
Arbovirus Infections/virology , Chikungunya Fever/epidemiology , Coinfection/epidemiology , Disease Outbreaks , Adolescent , Antibodies, Viral/blood , Arbovirus Infections/epidemiology , Arbovirus Infections/immunology , Chikungunya Fever/immunology , Chikungunya Fever/virology , Chikungunya virus/isolation & purification , Child , Coinfection/immunology , Coinfection/virology , Dengue/epidemiology , Dengue Virus/genetics , Dengue Virus/isolation & purification , Female , Genotype , Haiti/epidemiology , Humans , Male , Phylogeny , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction , Serogroup , Zika Virus/genetics , Zika Virus/isolation & purification , Zika Virus Infection/epidemiologyABSTRACT
In the 20th century, socioeconomic and environmental changes facilitated the reintroduction of mosquitoes in developing cities, resulting in the reinsertion of mosquito-borne viral diseases and the dispersal of their causative agents on a worldwide scale. Recurrent outbreaks of arboviral diseases are being reported, even in regions without a previous history of arboviral disease transmission. Of note, arboviral infections represented approximately 30% of all emerging vector-borne diseases in the last decade. Therapeutic strategies against infectious viral diseases include the use of different classes of molecules that act directly on the pathogen and/or act by optimizing the host immune response. Drugs targeting the virus usually provide amelioration of symptoms by suppressing and controlling the infection. However, it is limited by the short-window of effectiveness, ineffectiveness against latent viruses, development of drug-resistant mutants and toxic side effects. Disease may also be a consequence of an excessive, uncontrolled or misplaced inflammatory response, treatments that interfere in host immune response are interesting options and can be used isolated or in combination with virus-targeted therapies. The use of host-targeted therapies requires specific knowledge regarding host immune patterns that may trigger dengue virus (DENV), chikungunya virus (CHIKV) or Zika virus (ZIKV) disease.
Subject(s)
Antiviral Agents/pharmacology , Arbovirus Infections/drug therapy , Arbovirus Infections/virology , Arboviruses/drug effects , Arboviruses/immunology , Animals , Arbovirus Infections/immunology , HumansABSTRACT
QUESTIONS INVESTIGATED: The recent emergence of arboviruses such as Chikungunya virus (CHIKV) and Zika virus (ZIKV) in Brazil has posed a threat to human health and to the country's economy. Outbreaks occur mainly in tropical areas; however, increasing number of cases have been observed in Rio Grande do Sul (RS), the Southernmost state; therefore, surveillance of these arboviruses is essential for public health measures. DESIGN: In this study, we analyzed 1276 samples from patients with clinically suspected arboviral diseases between 2014 and 2016. Demographic and clinical data were collected and described; cases of microcephaly associated with congenital infection were analyzed. ESSENTIAL FINDINGS: Results show that CHIKV and ZIKV entered RS in 2014 and 2015, respectively, with imported cases confirmed. Autochthonous infections occurred in 2016 for both viruses, with a total of 5 autochthonous cases for CHIKV and 44 for ZIKV. Most patients were older than 21 years; the main symptoms were fever, arthralgia, myalgia, and headache; rash, conjunctivitis, and pruritus were also reported in ZIKV cases. Three cases of congenital Zika syndrome were confirmed in our study, while another 20 cases of microcephaly associated with congenital infection were confirmed (10 positive for syphilis, 6 for toxoplasmosis and 4 for cytomegalovirus). MAIN CONCLUSIONS: Considering co-circulation of different arbovirus in RS, including Dengue virus, CHIKV, and ZIKV, and the presence of Aedes aegypti and Aedes albopictus in the area, surveillance of patients infected by these viruses contributes to the control and prevention of such diseases. Practical difficulties in diagnosing these infections are discussed.
Subject(s)
Arbovirus Infections/epidemiology , Arbovirus Infections/virology , Arboviruses , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/virology , Public Health Surveillance , Adolescent , Adult , Aged , Antibodies, Viral/immunology , Arbovirus Infections/immunology , Arbovirus Infections/transmission , Arboviruses/genetics , Arboviruses/immunology , Brazil/epidemiology , Chikungunya Fever/epidemiology , Chikungunya Fever/immunology , Chikungunya Fever/transmission , Chikungunya Fever/virology , Chikungunya virus/genetics , Chikungunya virus/immunology , Child , Child, Preschool , Communicable Diseases, Emerging/immunology , Communicable Diseases, Emerging/transmission , Female , Geography, Medical , Humans , Infectious Disease Transmission, Vertical , Male , Middle Aged , RNA, Viral , Young Adult , Zika Virus/genetics , Zika Virus/immunology , Zika Virus Infection/epidemiology , Zika Virus Infection/immunology , Zika Virus Infection/transmission , Zika Virus Infection/virologyABSTRACT
BACKGROUND: Meningoencephalitis is one of the most common disorders of the central nervous system (CNS) worldwide. Viral meningoencephalitis differs from bacterial meningitis in several aspects. In some developing countries, bacterial meningitis has appropriate clinical management and chemotherapy is available. Virus-associated and virus not detected meningoencephalitis are treatable, however, they may cause death in a few cases. The knowledge of how mediators of inflammation can induce disease would contribute for the design of affordable therapeutic strategies, as well as to the diagnosis of virus not detected and viral meningoencephalitis. Cytokine-induced inflammation to CNS requires several factors that are not fully understood yet. METHODS: Considering this, several cytokines were measured in the cerebrospinal fluid (CSF) of patients with undiagnosed and viral meningoencephalitis, and these were correlated with cellularity in the CSF. RESULTS: The results demonstrate that an altered biochemical profile alongside increased cellularity in the cerebrospinal fluid is a feature of patients with meningoencephalitis that are not associated with the detection of virus in the CNS (P < 0.05). Moreover, HIV-positive patients (n = 10) that evolve with meningoencephalitis display a distinct biochemical/cytological profile (P < 0.05) in the cerebrospinal fluid. Meningoencephalitis brings about a prominent intrathecal cytokine storm regardless of the detection of virus as presumable etiological agent. In the case of Enterovirus infection (n = 13), meningoencephalitis elicits robust intrathecal pro-inflammatory cytokine pattern and elevated cellularity when compared to herpesvirus (n = 15) and Arbovirus (n = 5) viral infections (P < 0.05). CONCLUSION: Differences in the cytokine profile of the CSF may be unique if distinct, viral or presumably non-viral pathways initially trigger the inflammatory response in the CNS.
Subject(s)
Arbovirus Infections/cerebrospinal fluid , Cytokines/cerebrospinal fluid , Enterovirus Infections/cerebrospinal fluid , HIV Infections/cerebrospinal fluid , Herpesviridae Infections/cerebrospinal fluid , Lentivirus Infections/cerebrospinal fluid , Meningoencephalitis/cerebrospinal fluid , Arbovirus Infections/diagnosis , Arbovirus Infections/immunology , Central Nervous System Viral Diseases/cerebrospinal fluid , Central Nervous System Viral Diseases/diagnosis , Central Nervous System Viral Diseases/immunology , Coinfection/cerebrospinal fluid , Coinfection/immunology , Cross-Sectional Studies , Cytokines/immunology , DNA, Viral/cerebrospinal fluid , Enterovirus Infections/diagnosis , Enterovirus Infections/immunology , HIV Infections/diagnosis , HIV Infections/immunology , Herpesviridae Infections/diagnosis , Herpesviridae Infections/immunology , Humans , Inflammation , Interferon-gamma/cerebrospinal fluid , Interferon-gamma/immunology , Interleukin-10/cerebrospinal fluid , Interleukin-10/immunology , Interleukin-12/cerebrospinal fluid , Interleukin-12/immunology , Interleukin-17/cerebrospinal fluid , Interleukin-17/immunology , Interleukin-6/cerebrospinal fluid , Interleukin-6/immunology , Lentivirus Infections/immunology , Meningoencephalitis/diagnosis , Meningoencephalitis/immunology , RNA, Viral/cerebrospinal fluid , Tumor Necrosis Factor-alpha/cerebrospinal fluid , Tumor Necrosis Factor-alpha/immunologyABSTRACT
Coues rice rat (Oryzomys couesi), a species abundant throughout Central America, was evaluated experimentally for the ability to serve as an amplifying host for three arboviruses: Patois (Bunyaviridae, Orthobunyavirus), Nepuyo (Orthobunyavirus), and Venezuelan equine encephalitis virus subtype ID (Togaviridae, Alphavirus). These three viruses have similar ecologies and are known to co-circulate in nature. Animals from all three cohorts survived infection and developed viremia with no apparent signs of illness and long-lasting antibodies. Thus, O. couesi may play a role in the general maintenance of these viruses in nature.
Subject(s)
Arbovirus Infections/virology , Arboviruses/pathogenicity , Sigmodontinae , Animals , Antibodies, Viral/blood , Arbovirus Infections/immunology , Hemagglutination Inhibition Tests , MexicoABSTRACT
OBJECTIVE: To know the arbovirus causing hemorrhagic fever in patients at the Mexican Institute of Social Security. MATERIAL AND METHODS: A follow-up study was made in patients with probable diagnosis of hemorrhagic dengue. Blood samples were taken to look for dengue fever, yellow fever and San Luis, Tonate and Mayaro encephalitis viruses. Frequencies and proportions of the interest variables were analyzed. RESULTS: 35 patients were studied. Isolation and PCR results of the 13 samples were negative in 12 of them and positive to denguevirus-3 in one of them. The determination of IgM was positive for dengue fever in 25 cases; 2 were positive to Mayaro virus and 8 were negative to what was looked for. Hemorrhages and thrombocytopenia were more frequent in patients infected with dengue and Mayaro viruses; jaundice and encephalopathy were more frequent in the latter, and renal dysfunction, in patients with a negative result. Evolution was satisfactory in all cases, except for one (Mayaro), which presented hemorrhages, thrombocytopenia, jaundice and encephalopathy that lead to death. CONCLUSIONS: The results show the risk of appearance and dissemination of several vector-born diseases in Mexico. Thus, they require intensive epidemiological surveillance to identify them and to know their real occurrence and specific clinical profile.
Subject(s)
Arbovirus Infections/complications , Severe Dengue/virology , Arbovirus Infections/epidemiology , Arbovirus Infections/immunology , Immunoglobulin M/immunology , Mexico/epidemiology , Polymerase Chain Reaction , Severe Dengue/epidemiologyABSTRACT
The authors describe the baseline malaria prevalence and arbovirus seroprevalence among 467 subjects in an ongoing cohort study in rural Amazonia. Most subjects (72.2%) reported one or more previous episodes of malaria, and 15.6% had been hospitalized for malaria, but only 3.6% of individuals five years or older had malaria parasites detected by microscopy (10 with Plasmodium vivax and 4 with P. falciparum). Antibodies to Alphavirus, Orthobunyavirus, and/or Flavivirus were detected by hemagglutination inhibition (HI) in 42.6% of subjects aged five years or older, with a higher seropositivity rate among males (49.2%) than females (36.2%). Since 98.9% of subjects had been immunized for yellow fever, the presence of cross-reactive antibodies to dengue and other Flaviviruses cannot be ruled out, but at least 12 subjects (3.3%) with IgM antibodies to dengue virus detected by ELISA had a putative recent exposure to this virus.
Subject(s)
Arbovirus Infections/epidemiology , Endemic Diseases , Malaria/epidemiology , Adolescent , Adult , Antibodies, Viral/blood , Arbovirus Infections/immunology , Arboviruses/immunology , Brazil/epidemiology , Child , Child, Preschool , Cross Reactions , Dengue Virus/immunology , Ecosystem , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin G/blood , Infant , Malaria/immunology , Male , Middle Aged , Prevalence , Rural Population , Seroepidemiologic Studies , Sex FactorsABSTRACT
The authors describe the baseline malaria prevalence and arbovirus seroprevalence among 467 subjects in an ongoing cohort study in rural Amazonia. Most subjects (72.2 percent) reported one or more previous episodes of malaria, and 15.6 percent had been hospitalized for malaria, but only 3.6 percent of individuals five years or older had malaria parasites detected by microscopy (10 with Plasmodium vivax and 4 with P. falciparum). Antibodies to Alphavirus, Orthobunyavirus, and/or Flavivirus were detected by hemagglutination inhibition (HI) in 42.6 percent of subjects aged five years or older, with a higher seropositivity rate among males (49.2 percent) than females (36.2 percent). Since 98.9 percent of subjects had been immunized for yellow fever, the presence of cross-reactive antibodies to dengue and other Flaviviruses cannot be ruled out, but at least 12 subjects (3.3 percent) with IgM antibodies to dengue virus detected by ELISA had a putative recent exposure to this virus.
Subject(s)
Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged , Arbovirus Infections/epidemiology , Endemic Diseases , Malaria/epidemiology , Antibodies, Viral/blood , Arbovirus Infections/immunology , Arboviruses/immunology , Brazil/epidemiology , Cross Reactions , Dengue Virus/immunology , Ecosystem , Enzyme-Linked Immunosorbent Assay , Immunoglobulin G/blood , Malaria/immunology , Prevalence , Rural Population , Seroepidemiologic Studies , Sex FactorsSubject(s)
Antibodies, Antineutrophil Cytoplasmic/immunology , Arbovirus Infections/complications , Arboviruses/pathogenicity , Autoimmune Diseases/etiology , Granulomatosis with Polyangiitis/etiology , Antibodies, Viral/blood , Antibodies, Viral/immunology , Arbovirus Infections/immunology , Arboviruses/immunology , Autoimmune Diseases/immunology , Glomerulonephritis/etiology , Glomerulonephritis/immunology , Granulomatosis with Polyangiitis/immunology , Humans , Immunoglobulin G/blood , Immunoglobulin G/immunology , Molecular Mimicry , Neutrophils/immunologyABSTRACT
Embryonic tissue explants of the sand fly Lutzomyia longipalpis (Lutz & Neiva 1912) the main vector of Leishmania chagasi (Cunha and Chagas), were used to obtain a continuous cell line (Lulo). The tissues were seeded in MM/VP12 medium and these were incubated at 28ºC. The first subculture was obtained 45 days after explanting and 96 passages have been made to date. Lulo is composed of epithelioid cells, showed a 0.04 generations/hour exponential growth rate and population doubling time at 24.7 h. The cell line isoenzymatic profiles were determined by using PGI, PGM, MPI and 6-PGDH systems, coinciding with patterns obtained from the same species and colony's pupae and adults. The species karyotype characteristics were recognized (2n = 8), in which pair 1 is subtelocentric and pairs 2, 3 and 4 are metacentric. Lulo was free from bacterial, fungal, mycoplasmic and viral infection. Susceptibility to five arbovirus was determined, the same as Lulo interaction with Leishmania promastigotes.
Subject(s)
Animals , Female , Arbovirus Infections , Leishmania infantum , Leishmaniasis, Visceral , Psychodidae/cytology , Arbovirus Infections/immunology , Arboviruses/growth & development , Cell Line , Disease Susceptibility , Epithelioid Cells , Leishmania infantum/immunology , Leishmaniasis, Visceral/immunologyABSTRACT
This is a review of the arboviruses in Argentina belonging to families Flaviviridae, Bunyaviridae and Rhabdoviridae. Of the many viruses beloging to these families, the flavivirus St. Louis encephalitis (SLE), has been most intensively studies. SLE virus strains have been recovered from three sources: 2 strains from humans with an undifferentiated, febrile disease; 6 from mosquitoes; and 2 from rodents. The viruses recovered from rodents are attenuated and those from mosquitoes are virulent based on a neuroinvasiveness test in mice; the degree of virulence of the mosquito strains remain to be analyzed. Serological surveys indicate a wide distribution and endemicity of SLE virus in the temperate and subtropical areas (central and northern Argentina), but no data are available from the Andean region or from the South. The virulent SLE virus strains appear to be transmitted between Culex (Cx.) spp., from which they were isolated, and wild birds, based on antibody prevalence. A urban cycle may involve Cx. quinquefasciatus (source of a viral isolate and a competent experimental vector) and abundant birds (house sparrows, doves, and/or chickens), chickens are experimentally competent host species. Despite similarities in the ecology of SLE between Argentina and North America, urban outbreaks of SLE have not recognized. Possible explanations for this discrepancy include virus strain differences in virulence, ecologic factors determining the rate os virus transmission, and the lack of disease recognition and specific laboratory diagnosisof human meningoencephalitis. The transmission cycle of attenuated SLE virus strains isolated from rodents has not been studied. Ilheus virus has been isolated only once from a human being. The available serological data are difficult to interpret due to cross-reactivity with other flaviviruses, and the ecology and medical importance of this agent remain uncertain. Dengue has not been recognized in Argentina since 1916, although its vector, Aedes aegypti, was not eradicated until 1963. Dengue was previously present in coastal localities of Chaco, Corrientes and Misiones Provinces. Within the last few years, Argentina was reinfested by Ae. aegypti. Although no human cases have yet been reported, outbreaks of dengue in bordering countries (Brazil, Paraguay, Bolovia) since 1986, clearly signal that the country in once again at risk of importation and spread of the viruse